Shopping Cart
Remove All
Your shopping cart is currently empty
BIIB129 is a selective and brain-penetrant BTK covalent inhibitor used to study B-cell proliferation-related diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $64 | In Stock | In Stock | |
| 5 mg | $156 | In Stock | In Stock | |
| 10 mg | $222 | In Stock | In Stock | |
| 25 mg | $378 | In Stock | In Stock | |
| 50 mg | $569 | In Stock | In Stock | |
| 100 mg | $795 | - | In Stock | |
| 200 mg | $1,070 | - | In Stock |
| Description | BIIB129 is a selective and brain-penetrant BTK covalent inhibitor used to study B-cell proliferation-related diseases. |
| In vitro | BIIB129 inhibited the activation and translocation of NF-κB to the nucleus in TMD8 cells, IC50 = 1.9 nM; In human peripheral blood mononuclear cells (PBMCs), IC50 = 13 nM inhibits anti-IGD-induced B-cell activation. |
| In vivo | A mouse model of oral BIIB129 (BID 0.1, 0.3, 1, 3.2, 10, and 31.7 mg/kg, respectively) showed a dose-dependent reduction in Ki67+ microglia proliferation and EC50 = 1.5 mg/kg. |
| Synonyms | BIIB 129 |
| Molecular Weight | 366.42 |
| Formula | C19H22N6O2 |
| Cas No. | 2770960-52-4 |
| Smiles | O(C=1C=2N(C=C(N1)C3=CN(C)N=C3)N=CC2)[C@@]4(C)C[C@@H](N(C(C=C)=O)C)C4 |
| Color | Yellow |
| Appearance | Solid |
| Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (218.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (9.01 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.